• News

    News from Oxford Biosystems

    News from Oxford Biosystems

From category archives: Oxford Biosystems Latest News

Infectious Diseases

Neutralising SARS-CoV-2 antibodies

The Spike Protein of SARS-CoV-2 is a trimer made up of S1 and S2 proteins.

The Receptor Binding Domain (RBD) of S1 binds to the ACE2 receptor in the cell membrane to gain access to the host cell. Spike antigens trigger the host’s cellular immune system resulting in the B cells producing antibodies against Spike antigens.

Read the rest of entry »

Improve Clinical Management

Influenza is an acute viral infection of the respiratory tract that can cause...

Read the rest of entry »

New Chlamydia serology test

Testline add to their range of Chlamydia serology products...

Read the rest of entry »

Urinary Antigen Testing

Pneumonia is a common illness affecting approximately 450 million people a year and occurring in all parts of the world. It is a major cause of death among all age groups, resulting in 4 million deaths annually – 7% of total world annual deaths.1

Read the rest of entry »

Antibiotic Guardian

Oxford Biosystems has pledged to be an Antibiotic Guardian

Antibiotic resistance is one of the biggest threats facing us today.

Without effective antibiotics many routine treatments will become increasingly dangerous. Setting broken bones, basic operations, even chemotherapy and animal health all rely on access to antibiotics that work.

Read the rest of entry »

Manage Human MxA Protein

Human MxA protein (Myxovirus resistance protein 1), the product of the MX1 gene, is a 76-kDa protein consisting of 662 amino acid residues and belonging to the dynamic superfamily of large GTPase. MxA protein plays an important role in antiviral activity in cells against a wide variety of viruses. These include:

Read the rest of entry »

Oxford Biosystems

184B Park Drive
Milton Park
Abingdon
Oxon
OX14 4SE

Oxford Biosystems has pledged to be an Antibiotic Guardian

members of